Houston, TX, United States of America

Rajagopal Ramesh



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Rajagopal Ramesh: Innovator in Non-Viral Gene Therapy**

Introduction

Rajagopal Ramesh is a notable inventor based in Houston, TX, renowned for his groundbreaking contributions to the field of gene therapy. With a focus on innovative methods and compositions for tackling hyperproliferative diseases, Ramesh's work exemplifies the intersection of science and technology.

Latest Patents

Ramesh holds a significant patent titled "Methods and Compositions for Non-Viral Gene Therapy for Treatment of Hyperproliferative Diseases." This invention details non-viral gene therapy methods and compositions aimed at effectively treating hyperproliferative diseases in humans. Specifically, it introduces lipid formulations that create stable liposome structures to enable efficient in vivo nucleic acid transfer. The method also emphasizes cell-specific targeting moieties for anti-proliferative nucleic acids, making it a promising approach for targeted gene therapy.

Career Highlights

Throughout his career, Rajagopal Ramesh has made substantial contributions to the field while working with various esteemed organizations. He has been associated with the University of Texas System, where he contributed to advanced research in genetics and therapy. Additionally, he worked at Introgen Research Institute, Inc., furthering the development of innovative therapeutic strategies.

Collaborations

Ramesh has collaborated with prominent figures in the research community, including Jack A. Roth and Tomoyuki Saeki. These collaborations have enriched his work by integrating diverse insights and expertise, enhancing the development of his innovative approaches to gene therapy.

Conclusion

In summary, Rajagopal Ramesh's contributions to the field of gene therapy highlight his innovative spirit and commitment to improving healthcare solutions. His patented methods for non-viral gene therapy present significant advancements in the treatment of hyperproliferative diseases, showcasing the potential of targeted gene therapies in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…